21st Century Neurology, a division of Xenoscience, Inc.

Phoenix, Arizona 85013

0 studies enrolling now · 4 studies all time

What they study most

Alzheimer's Disease, Chronic Migraine, Epilepsy, Episodic Migraine

Studies at this site

• A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine — Running, not enrolling
• A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine — Running, not enrolling
• Tricaprilin in Mild to Moderate Alzheimer's Disease — Completed
• Eslicarbazepine Acetate Monotherapy Long Term Study — Completed